Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

SHOCKING: 15 - You Need To See This

Scottish Mortgage sees share price fall by a third

Net asset value also fell by more than 17% during a year that has been 'painful for shareholders'

Insider UK · May 17, 2023

These Next-Generation Vaccines Could Upend Cancer Treatment As We Know It

New high-tech vaccines could help combat common yet deadly conditions like cancer and heart disease.

Inverse · May 15, 2023

The Vaccine Problem

To better weather future pandemics, the way countries procure vaccines needs to change radically

The Walrus · May 15, 2023

From analysis to the latest developments in health,
read the most diverse news in one place.

mRNA technology beat COVID-19, can it do the same for pancreatic cancer?

Half the pancreatic cancer patients in a new clinical trial were alive and cancer free after 18 months. Most usually die within three months.

The New Daily · May 10, 2023

FDA approves first vaccine for respiratory syncytial virus

The FDA has approved the first vaccine for respiratory syncytial virus (RSV).

The Hindu · May 6, 2023

Moderna Stock Pops on Surprise Earnings Beat

An unexpected profit and promising news on a deal with the EU boosted Moderna stock.

Kiplinger · May 4, 2023

Attorney General Ken Paxton to investigate COVID-19 vaccine makers

Long an opponent of vaccine and mask mandates, the Republican said pharmaceutical companies may have misrepresented data. Pfizer strongly disagrees.

The Texas Tribune · May 2, 2023

Read news from The Economist, FT, and more,
with one subscription

Lyme disease: vaccine could halt rise of tick-borne disease

A vaccine for Lyme disease could be available soon, according to reports.

The Week · Apr 28, 2023

Moderna's CEO shares what it was like to leap from pre-revenue startup to Fortune 500 company

The COVID-19 vaccine turned Moderna into a household name. What's next for the company?

Fortune · Apr 26, 2023

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

The Independent UK · Apr 21, 2023

Extra spring COVID booster cleared for certain Americans

Certain Americans at high risk from COVID-19 can get an extra vaccine booster this spring

The Independent UK · Apr 18, 2023

Autumn Covid booster 2023: Who is eligible for another jab?

If invited, you will receive a booster dose of a Covid-19 vaccine made by Pfizer, Moderna, or Sanofi

Evening Standard · Apr 17, 2023

Sanofi: the new protein-based Covid vaccine to be used in the UK

The University of Edinburgh’s Neil Mabbott on the vaccine technology being used for Covid booster jabs from this month.

The Week · Apr 17, 2023

Study: Vaccine helps drug keep melanoma patients cancer-free

Adding a personalized cancer vaccine to the blockbuster drug Keytruda kept more melanoma patients in remission than the immune therapy alone, co-developers Moderna Inc. and Merck & Co. said in their first detailed presentation of a key study.

Tribune News Service · Apr 16, 2023

Get all your
news in one place.

100's of premium titles.
One news app.

Wales Online · Apr 15, 2023

Everything we know about new Sanofi Covid vaccine now being used in UK

The vaccine being used in the Spring booster campaign works in a different way to previous jabs

The Conversation · Apr 14, 2023

Sanofi vaccine: what to know about this protein-based COVID booster being offered in the UK

In the UK a spring booster campaign has recently begun, offering an additional vaccine to people at highest risk from COVID. Between April and June 2023 people aged over 75, residents in care homes and children and adults aged five and up with weakened immune systems will be invited to…

Wales Online · Apr 8, 2023

Cancer and heart disease vaccines could be ready 'by the end of the decade'

The speed of which the Covid jab was developed has "unspooled" medical advancements

Manchester Evening News · Apr 8, 2023

Vaccines for cancer could be ready by 2030, according to Moderna chief

The pharmaceutical firm said it is confident the jabs for cancer could be ready by the end of the decade

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK · Apr 8, 2023

‘Groundbreaking’ cancer and heart disease vaccine ‘could save millions of lives’

Experts hope new vaccines will be ready by end of decade

The Guardian - UK · Apr 7, 2023

‘A silver lining’: how Covid ushered in a vaccines golden era

Pandemic accelerated advances in vaccine technology, opening up possibilities for combating array of diseases

The Guardian - UK · Apr 7, 2023

Cancer and heart disease vaccines ‘ready by end of the decade’

Exclusive: Pharmaceutical firm says groundbreaking jabs could save millions of lives

Zenger · Mar 28, 2023

Being Vaccinated Halves Risk Of Long COVID: Study

It was based on 860,000 patients across the world. The post Being vaccinated halves risk of long COVID: study appeared first on Talker.

Tribune News Service · Mar 25, 2023

Lisa Jarvis: An urgently needed TB shot could democratize vaccines

Tuberculosis surrendered the title of the world’s deadliest infectious disease after COVID-19 struck, but it reclaimed that terrible distinction last year. As with COVID, a new vaccine could go a long way to sharply curtailing the disease, which killed about 1.4 million people a year before the pandemic and increased…

Tribune News Service · Mar 24, 2023

Sen. Bernie Sanders shows fire, but seeks modest goals, in his debut drug hearing as health chair

Sen. Bernie Sanders, who rose to national prominence criticizing big business in general and the pharmaceutical industry in particular, claimed the spotlight Wednesday on what might at first seem a powerful new stage from which to advance his agenda: chairmanship of the Senate health committee.

Los Angeles Times · Mar 24, 2023

Michael Hiltzik: Biden says he wants to bring down drug prices. His actions tell a different story

You might get the impression from the Biden administration's insulin price cut and its initiative allowing Medicare to negotiate over other pharmaceuticals that the drug pricing issue is finally being taken seriously in Washington.

1 … 14 15 16 17

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

University of Edinburgh

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.